Why Minoxidil Doesn’t Work for 50% of People
If you used minoxidil consistently and got nothing, the problem was probably never you. Whether the drug ever switches on depends on one enzyme in your scalp, and roughly half of people do not make enough of it. Here is the research, and how to find out where you stand.
By John Goss, Founder of Adegen
Last updated August 2026 · 8 min read
Most topical routines fail quietly: the drug is applied every day and never converted into its active form.
I hear this constantly.
Someone tried minoxidil for six months. They were consistent, they did not miss applications, and they waited out the full cycle.
And they got nothing.
Most of them arrive at the same conclusion:
Minoxidil does not work for me. My hair loss is too advanced. I am a lost cause.
That conclusion is wrong, and it is costing people real results.
I know the pattern personally. My family is full of pharmacists, and doctors I trusted put me on minoxidil and finasteride in my twenties.
I used both religiously. My hair loss kept getting worse.
That failure is a large part of why Adegen exists.
So let me be clear up front. I am not here to tell you minoxidil is bad. I am here to show you that most people who think they tested minoxidil never actually did.
You are not an unusual case, either. Roughly 93% of the customers we serve tried other treatments first, and about 4 in 10 of them used minoxidil or finasteride.
The reason it fails 40 to 50% of users has nothing to do with how advanced your hair loss is, how long you have been losing it, or anything about you personally.
It comes down to a single biochemical bottleneck at the follicle that almost nobody in this industry bothers to explain.
The failure was never yours. It was in the formulation.
Minoxidil Is Not What You Think It Is
Most people think of minoxidil as the active ingredient in their treatment.
It is not. Not in the form you apply it.
Minoxidil is a prodrug, a pharmacological term for a compound that is therapeutically inactive until your body converts it into something else.
The minoxidil in your bottle does nothing on its own. It has to be transformed before it can affect a single hair follicle.
The active compound is minoxidil sulfate.
That is what opens potassium channels in the cells around the follicle, improves nutrient and oxygen delivery to the root, and extends the anagen phase, which is the active growth phase of the hair cycle.[1]
Minoxidil sulfate is what reverses follicular miniaturization. Minoxidil itself is just the delivery vehicle.
That conversion happens in the outer root sheath cells of your follicles. It is carried out by an enzyme called sulfotransferase, particularly the isoform known as SULT1A1.
- 1Applied at the surface
Minoxidil lands on the scalp in its inactive prodrug form.
- 2Converted in the follicle
The SULT1A1 enzyme in the outer root sheath converts it to minoxidil sulfate.
- 3Active at the root
Minoxidil sulfate extends the growth phase. Without the conversion, this step never happens.
With enough SULT1A1 activity at your scalp, the conversion happens efficiently, minoxidil sulfate is produced, and the treatment works.
Without it, the conversion is incomplete. The minoxidil sits there unactivated.
You apply it every day and your follicles never receive the compound that was supposed to help them.
That is the enzyme gap. It is why a drug that works well for one person does nothing for the person sitting next to them.
And if that conversion never happens, you are not using a weaker version of the treatment. You are effectively not using the treatment at all.
The question was never whether minoxidil works. It is which side of the conversion line your scalp is on.
Not sure which side you are on? Your treatment history holds the answer →
Half the people told minoxidil failed them never received the active compound at all.
In a study of patients at a hair loss clinic, low scalp sulfotransferase activity showed up at almost exactly the same rate as clinical non-response to minoxidil.[2]
The two numbers line up too well to ignore.
The Test Exists. Nobody Offered It to You.
This is not a fringe theory, and it is not new.
Goren et al. (2015), Dermatologic Therapy
This study of patients presenting at a hair loss clinic found that 49.3% of subjects had low sulfotransferase activity in their scalp tissue.[2] That number maps almost exactly onto the clinical non-response rate seen in minoxidil trials. The enzyme gap and the non-response problem are the same problem.
Roberts et al. (2014), Dermatologic Therapy
Independent researchers showed that sulfotransferase activity measured in plucked hair follicles could predict minoxidil response in women with androgenetic alopecia with 93 to 95% sensitivity and 73 to 83% specificity.[3] A simple lab test on a few plucked hairs, run before you ever start treatment, can tell you with reasonable accuracy whether standard minoxidil is going to work for you. The test exists. Most prescribers never mention it.
A 2022 review confirmed what the clinical data keeps showing. Enzyme activity in the hair follicle is a reliable prognostic marker for minoxidil response, and the variation between individuals is primarily genetic.[4]
This is not a deficiency you caused. It is not something you fix by applying more product or being more consistent.
It is biochemistry.
All three papers point the same direction. A significant share of everyone told minoxidil did not work for them was never a non-responder to the treatment at all.
They were a non-responder to an incomplete formulation.
Sulfotransferase expression varies a lot from person to person. Some people are born with lower SULT1A1 activity in scalp tissue.
Others have adequate systemic enzyme levels but reduced expression at the follicle specifically, which is exactly where the conversion needs to happen.
There is currently no simple consumer test for your sulfotransferase status. The tests that do exist live in research labs and dermatology offices.
Which means most people discover they have low enzyme activity the hard way: after months of consistent use with nothing to show for it.
So why did nobody tell you?
The honest answer is less dramatic than a cover-up. The research has been in the published literature since the 1990s, the Goren follicle-testing work has been replicated, and the Sharma study is sitting in PubMed.
The fix involves a prescription compound, and there is no approved off-the-shelf product that combines it with minoxidil. It has to be compounded to order.
So most prescribers simply write for what is commercially available.
Beyond that, the companies selling generic minoxidil have no financial incentive to complicate a product that already dominates the market.
Nobody is hiding the research. It just never made it into the bottle you bought.
The lab test is out of reach. Your treatment history is not. That is exactly why we built the HairIQ assessment: it weighs 160+ clinical decision rules against roughly 25,000 possible combinations of pattern, history, and treatment response, and it reads the strongest signal available, which is what you used, how long you used it, and what happened.
Find out what your minoxidil results were telling you →The Fix Has Been in the Literature Since 1986
So the question becomes: can you increase that enzyme activity?
The answer is yes. And the compound that does it has been in the published literature for decades.
Tretinoin, the prescription-grade form of retinoic acid, directly upregulates sulfotransferase expression at the follicular level.
In plain terms, it increases your scalp’s capacity to convert minoxidil into the compound that actually works. It addresses the bottleneck directly, and it does this two ways.
Delivery: more of the drug reaches the follicle
Tretinoin increases epidermal turnover and thins the stratum corneum, the outermost layer of skin. That improves penetration of minoxidil deeper into the follicle, where the conversion needs to occur.
Conversion: more of the enzyme to convert it
More significantly for non-responders, tretinoin upregulates the expression of SULT1A1 itself. It does not just move the minoxidil closer to the enzyme. It produces more of the enzyme.
of people whose enzyme levels predicted failure on minoxidil moved into the responding range after five days of topical tretinoin (Sharma 2019).[6]
The enzyme moved first. Hair takes months.
Nobody regrows hair in five days, and you should distrust anyone who says otherwise.
What Sharma showed is that the enzyme deficit blocking their response was partially corrected in under a week. The regrowth still runs on the hair cycle’s clock.
And Sharma is only the most recent entry. The same combination has produced the same signal in independent research for four decades.
- 1986Bazzano, JAAD
Tretinoin + 0.5% minoxidil produced terminal hair regrowth in 66% of subjects after one year. A small open-label study, but the earliest signal.[7]
- 1990Ferry, Clin. Pharm. & Therapeutics
Tretinoin significantly improves percutaneous absorption of minoxidil from topical solutions. More minoxidil reaching the follicle means more substrate for the enzyme to convert.[8]
- 2007Kwon, J. Korean Med. Science
Minoxidil combined with tretinoin additively enhanced human hair growth in vitro. The combination protected the follicle while also promoting active growth.[9]
- 2019Sharma, Dermatologic Therapy
43% of predicted non-responders crossed the response threshold after five days of topical tretinoin.[6]
Terminal hair, for the record, is fully pigmented, full-diameter hair, not the fine vellus hair that represents incomplete response. Two thirds of subjects regrowing terminal hair is a meaningful clinical outcome.
The pattern across four decades of independent research is consistent. Tretinoin and minoxidil work better together than either does alone.
For people with adequate enzyme activity, the combination produces stronger results. For people with low activity, it may be the difference between a response and no response at all.
Enzyme activity exists on a spectrum. Some people have very high activity and respond strongly to standard minoxidil. Some have essentially none locally and will not respond regardless of how much they apply.
And there is a large group in the middle who respond partially, inconsistently, or more slowly than expected.
Addressing the enzyme bottleneck benefits all three groups, including the people who were already responding.
Four decades of research, and it still is not in the bottle you already tried. HairIQ tells you what your protocol should have included all along: your pattern named, what is most likely driving it, and the strength and combination your case calls for instead of the average one.
See what your protocol should have included →What Happens When the Conversion Works
Regrowth does not announce itself overnight.
Hair grows on a biological clock no formula can skip. The growth phase runs roughly 90 to 100 days, which is why most people begin noticing changes around the three-month mark, with density building well beyond it.
What that looks like in real life is quieter than an ad.
The drain catches less hair. The part stops widening, then starts narrowing.
Somewhere around month four, someone who does not know you are treating it mentions your hair looks different.
The reviews that matter most for this article are the ones from people whose minoxidil run had already failed:
“I’ve been using minoxidil for well over 10 years, which slowed my hair loss, but didn’t stop it. I started trying Adegen recently and can honestly say it has stopped my hair loss and I have regrown some hair.”
Todd W Huddleston Verified Trustpilot review · October 2025“I am an almost 62 year old female... after 10 years of trying everything for my hair loss, this is the ONLY thing that has offered dramatic, positive results.”
Julie Dornisch Verified Trustpilot review · November 2025One of them sent photos.
Spencer had spent years on the treadmill this article describes: supplements, natural topicals, laser caps, and a minoxidil run his scalp never responded to. These photos are from March 23 to July 9 on the formulation built for non-responders.
Spencer’s progress, March 23 to July 9. Individual results vary and are not guaranteed.
“I got to the point that for the sake of my emotional and mental health, I would turn off my bathroom light while I showered… It was too hard to see the hair accumulate on my hands as I shampooed and then watch the thinning of my hair in the mirror afterwards.”
“Because of my history with hair loss, I expect hair growth attempts to fail. But this time it’s different.”
“I’ve received so many compliments on my hair and I honestly don’t even think about hair loss anymore. Which is incredible because it consumed hours of my day prior to this.”
Spencer JacksonTheir experience matches what we track across the customer base:
*Customer tracking data. Individual results vary and are not guaranteed.
None of these people changed how hard they were trying.
Same drug. Different formulation. That is the whole difference.
These are people whose last bottle failed them too. The difference was not willpower. It was a protocol matched to what was actually driving their loss, and HairIQ builds yours from your answers rather than the average person’s.
Start my free HairIQ assessmentFree, takes about a minute. See your full results without creating an account.
Why We Built the Formula This Way
If you used a standard over-the-counter minoxidil product and saw nothing, you have not necessarily tested what minoxidil can do for your follicles.
You have tested what minoxidil can do without addressing the enzyme bottleneck. Those are not the same experiment.
One tests whether minoxidil can work. The other tests whether it was ever given the chance to.
Standard OTC minoxidil contains no tretinoin. It makes no attempt to address the enzyme gap.
For people with strong baseline enzyme activity, it works reasonably well. For the 40 to 50% with low activity, it is an incomplete solution sold as a complete one.
When I built our formulas, putting tretinoin in every topical was not a feature decision. It was a prerequisite.
A minoxidil formula without tretinoin accepts a 40 to 50% failure rate as a design outcome. That was not acceptable to me.
-
Prescription tretinoin, in every topical
Every Adegen topical includes tretinoin. Not retinol. Tretinoin: the prescription-grade compound from the Sharma study, at a concentration only a licensed provider can prescribe.
-
Micronized minoxidil, under 10 microns
Standard minoxidil uses alcohol-based solvents that irritate the scalp and limit how consistently people actually apply it. Micronizing the particle under 10 microns means it penetrates more effectively with less solvent-driven irritation, and better tolerability translates directly into better real-world consistency.
-
ARB™, our proprietary complex
Conversion gets the drug working. DHT is what was shutting the follicle down in the first place. ARB™ is a fatty-acid complex designed to block DHT locally at the follicle’s androgen receptor, without the systemic effects of oral DHT blockers.
-
Compounded cold, in our own pharmacy
Tretinoin is one of the most delicate actives in a topical. It degrades with heat, light, and oxygen. So we compound without heat and protect the actives from light throughout formulation, in our CryoSafe process. The question is whether the tretinoin is still active when it reaches your scalp.
That is why our formulas require a prescription. Tretinoin is a prescription ingredient, and the concentration matters.
If you tried minoxidil before and got nothing, that is not a verdict on your hair.
It is a verdict on the formulation.
The Questions You Are Probably Still Holding
Is tretinoin harsh?
It can be, and I will not pretend otherwise. Some people experience irritation early on.
The micronized base cuts down the solvent load that drives most of it, and your provider can adjust the formulation if your skin needs it.
Will it work for me?
I cannot promise you it will, and I built the company.
What I can tell you is that enzyme activity is a spectrum, the combination helps every group on it, and the people it helps most are exactly the ones standard minoxidil left behind.
The honest requirement is consistency across the first 90 days. If you will not use it daily, do not start.
Then what actually varies between people?
Not whether tretinoin belongs in the formula. Everything around it: the minoxidil strength, whether a DHT blocker belongs in your protocol, how the base should handle your skin.
That is what the assessment works out.
The science is universal. The protocol is not.
What Happens After You Finish
Worth knowing before you start, because most people assume there is a catch.
- 1Right now, about a minute
You answer questions about your pattern, your history, and what you have already tried. No account, no card.
- 2Immediately after
You see your full results: your pattern named, the most likely driver, and the protocol your case calls for. Reading it costs nothing and commits you to nothing.
- 3Only if you go forward
A licensed physician reviews everything before anything is prescribed, and it is compounded in our own US-based pharmacy. Your card is authorized at checkout and charged only once a provider approves.
You see everything before you decide anything.
The Part That Does Not Wait
Hair loss is not a fixed state. It is a process.
Every month a follicle sits under unopposed DHT, it miniaturizes a little further, and the hair it pushes out comes back finer than the last one.
For a long stretch, that follicle is only dormant. Still alive, still able to come back if it gets what it needs.
It does not stay that way forever. Miniaturization eventually ends in a follicle no topical can bring back.
That is the part most people learn late.
Which is the uncomfortable arithmetic in this article. If you spent a year applying a formula your scalp could not activate, that year still counted against you.
Not because you did anything wrong. Because nothing was working while you assumed something was.
It is far easier to keep the hair you still have than to recover the hair you already lost.
You Have Two Choices
Option 1. Keep doing what you have been doing.
Another bottle. Another six months. Another quiet verdict about your own biology, drawn from an experiment that was never actually run.
A year from now you are roughly where you are today, still checking the same spot in the same mirror.
Still telling yourself nothing works.
Option 2. Spend about a minute on the assessment.
It reads what your months on minoxidil were actually telling you, names your pattern, and shows the protocol your case calls for.
A year from now, you could be looking at hair you had already written off.
It is not your fault the bottle did not work. It was never built for your scalp.
Now that you know why, the choice is yours.
Find out what your hair actually needs.
If you tried minoxidil and did not see results, the next step is not to give up. It is to fix the formulation.
The free HairIQ assessment weighs 160+ clinical decision rules against your pattern, your history, and what you have already tried.
In about a minute you get your pattern named, the most likely driver, and the complete protocol your case calls for, reviewed by a licensed physician before anything is prescribed.
Start my free HairIQ assessmentFree, takes about a minute. See your full results without creating an account.
What does the HairIQ assessment actually tell me?
It names your pattern, identifies what is most likely driving it, and builds a complete protocol for your case: the topical strength, whether a DHT blocker belongs in it, and the steps that support it. It weighs 160+ clinical decision rules against your answers, and a licensed physician reviews everything before anything is prescribed.
I already tried minoxidil. Why would this be different?
Because standard minoxidil never addressed the conversion step this article describes. If your scalp is low on SULT1A1, you were applying an inactive compound. Tretinoin raises conversion capacity, which is the difference between testing minoxidil and testing whether it was ever given the chance to work.
Why does it need a prescription?
Because tretinoin is a prescription compound. That gate is not a hurdle we added. It is the reason the formula can finally address the conversion step, and it is why the fix was never going to appear in an over-the-counter bottle.
How long until I see results?
Hair grows on a roughly 90 to 100 day cycle. Most people begin noticing changes around the three-month mark, with density continuing to build after that. Consistency over the first 90 days matters more than any other factor.
Do I have to buy anything?
No. The assessment is free and you see your full results either way. If the protocol makes sense to you, you can start it from your results page. If not, you will at least know what your current approach is missing.
Your pattern, the likely driver, and the protocol for your case. Start the free HairIQ assessment →
Sources
- Buhl AE, et al. Minoxidil sulfate is the active metabolite that stimulates hair follicles. Journal of Investigative Dermatology. 1994.
- Goren A, Naccarato T, et al. Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatologic Therapy. 2015.
- Roberts J, et al. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia. Dermatologic Therapy. 2014.
- Pietrauszka K, Bergler-Czop B. SULT1A1 as a prognostic marker for minoxidil response in androgenetic alopecia. Postepy Dermatologii i Alergologii. 2022.
- Hebbring SJ, et al. Human SULT1A1 gene: copy number differences and functional implications. Human Molecular Genetics. 2007.
- Sharma A, et al. Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Dermatologic Therapy. 2019.
- Bazzano GS, Terezakis N, Galen W. Topical tretinoin for hair growth promotion. Journal of the American Academy of Dermatology. 1986.
- Ferry JJ, et al. Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution. Clinical Pharmacology and Therapeutics. 1990.
- Kwon OS, Pyo HK, Oh YJ, et al. Promotive effect of minoxidil combined with all-trans retinoic acid (tretinoin) on human hair growth in vitro. Journal of Korean Medical Science. 2007.
This article is published by Adegen for educational purposes and is not medical advice. Individual results vary and are not guaranteed.
Compounded medications are prepared for individual patients pursuant to a prescription and are not FDA-approved. Prescription treatments require completion of a medical intake and approval by a licensed medical provider. Not all treatments are appropriate for all customers. Availability may vary by state.
US shipping only. Prescription products cannot be shipped to Alabama, Arkansas, Kentucky, Delaware, or South Carolina. Topical products cannot be shipped to Massachusetts.
See the protocol your case calls for.